Check – Detect – Protect

May is Melanoma and Skin Cancer Awareness Month

We encourage everyone to get checked and protect yourself from the sun this summer. It’s the perfect time to talk about skin cancer – the most common cancer in the United States for men and women. It’s important to choose a pharmacy with a wide variety of treatment options, expert clinical support, and the care and compassion you deserve.

Five Main Types of Skin Cancer 1

  • Basal and Squamous cell carcinoma – As the most common type of skin cancer, these cancers start in the top layer of skin (epidermis) and are often related to sun exposure.
  • Melanoma – Much less common and develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control.
  • Merkel Cell Carcinoma (MCC) – is a rare type of skin cancer that starts when neuroendocrine skin cells (Merkel cells) start to grow out of control.
  • Lymphoma of the skin – when a non-Hodgkin lymphoma starts only in the skin (not in other organs or tissues).
  • Kaposi Sarcoma – cancer that develops from the cells that line lymph or blood vessels. It usually appears as tumors on the skin or on mucosal surfaces such as inside the mouth, but can also develop in other parts of the body – lymph nodes, the lungs, or digestive tract.

Lower Your Risk

There is no sure way to prevent skin cancer. Some risk factors such as your age, race, and family history can’t be controlled. But there are things you can do to lower your risk of melanoma and other skin cancers2:

  • Stay in the shade.
  • Wear clothing that covers your arms and legs
  • Wear a hat with a wide brim to shade your face, head, ears, and neck.
  • Wear sunglasses that wrap around and block both UVA and UVB rays.
  • Use broad-spectrum sunscreen with a sun protection factor (SPF) of 15 or higher.
  • Avoid tanning beds.

Onco360 Dispenses the Latest Oncology Products to Treat Skin Cancer **

**This list is a small portion of the comprehensive medications Onco360 can provide. Contact your account team for a full listing.

Abraxane® (paclitaxel protein-bound particles for injectable suspension or albumin-bound)
Braftovi® (encorafenib)
Cotellic® (cobimetinib)
Erbitux® (cetuximab)
Erivedge® (vismodegib)
Keytruda® (pembrolizumab)

Libtayo® (cemiplimab)
Mekinist® (trametinib)
Mektovi® (binimetinib)
Odomzo® (sonidegib)
Opdivo® (nivolumab)
Rozlytrek® (entrectinib)
Tafinlar® (dabrafenib)
Tecentriq® (atezolizumab)
Yervoy® (ipilimumab)
Zelboraf® (vemurafenib)


If you are a provider and would like to refer to Onco360, click below:

How To Refer


Helpful Resources

If you would like to read further about skin cancer or prevention, here are some recommended resources:

SPOT Skin Cancer™

Melanoma Research Alliance

National Council on Skin Cancer Prevention



*2024 nomination by MMIT in the Independent Specialty Pharmacy category.